Stay updated with breaking news from Project Integrum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 today announced the launch of a new subbrand RenBiologics to represent the companys antibody discovery business division.
BEIJING — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced the launch of a new sub-brand, RenBiologics
Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 a global biotech company focusing on the discovery and development of novel antibody therapeutics today announces an antibody evaluation option and license agreement with Ona Therapeutics Ona a Spanish biotech company specialized in unravelling novel biology to design biopharmaceuticals attacking advanced cancer.
LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel...
Biocytogen Pharmaceuticals a global biotech company focusing on the discovery of novel antibody therapeutics today announces an antibody evaluation option and license agreement with Myricx Bio a UK biotech company focusing on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates ADCs.